Ecphora Capital
Overview
Ecphora Capital is a venture capital firm based in Baltimore, Maryland that invests in early-stage companies operating in the medtech, biomedical, medical device, and biotechnology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanochon | Jan 2026 | Seed | Lead |
| Sonogen Medical | Dec 2023 | Seed | Lead |
| CoapTech | May 2025 | Series B | Co-investor |
| Novel Microdevices | Jan 2023 | Series A | Co-investor |
| SereNeuro Therapeutics | Feb 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Deborah Hemingway
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ecphora Capital based?
Ecphora Capital is headquartered in Baltimore, Maryland, United States.
When was Ecphora Capital founded?
Ecphora Capital was founded in 2022.
How many portfolio companies does Ecphora Capital have?
Ecphora Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Ecphora Capital's portfolio?
Portfolio companies visible on Caplight include Nanochon, Sonogen Medical, CoapTech, Novel Microdevices, SereNeuro Therapeutics.
What was Ecphora Capital's most recent investment shown here?
Ecphora Capital's most recent investment in this portfolio sample was in Nanochon in 2026.
What sectors does Ecphora Capital focus on?
Ecphora Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Ecphora Capital focus on?
Ecphora Capital typically invests at the Early stage.
What is Ecphora Capital's AUM?
Ecphora Capital's assets under management are estimated between $15.0M and $15.0M.